Hereditary spherocytosis type 2
- Synonyms
- SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT; Spherocytosis type 2
Summary
Available tests
Check Related conditions for additional relevant tests.
Clinical tests (24 available)
Clinical features
Help- Abnormality of blood and blood-forming tissues
- Acanthocytosis
Acanthocytosis
- MedGen UID: 195801
- Concept ID: C0687751
- Finding: Disease or Syndrome
Abnormality of blood and blood-forming tissues
- Hemolytic anemia
Hemolytic anemia
- MedGen UID: 1916
- Concept ID: C0002878
- Finding: Disease or Syndrome
Abnormality of blood and blood-forming tissues
- Increased red cell osmotic fragility
Increased red cell osmotic fragility
- MedGen UID: 376594
- Concept ID: C1849478
- Finding: Finding
Abnormality of blood and blood-forming tissues
- Reticulocytosis
Reticulocytosis
- MedGen UID: 60089
- Concept ID: C0206160
- Finding: Finding
Abnormality of blood and blood-forming tissues
- Spherocytosis
Spherocytosis
- MedGen UID: 154301
- Concept ID: C0553720
- Finding: Finding
Abnormality of blood and blood-forming tissues
- Acanthocytosis
- Abnormality of metabolism/homeostasis
- Hyperbilirubinemia
Hyperbilirubinemia
- MedGen UID: 86321
- Concept ID: C0311468
- Finding: Finding
Abnormality of metabolism/homeostasis
- Hyperbilirubinemia
- Abnormality of the digestive system
- Jaundice
Jaundice
- MedGen UID: 43987
- Concept ID: C0022346
- Finding: Sign or Symptom
Abnormality of the digestive system
- Jaundice
- Abnormality of the immune system
- Splenomegaly
Splenomegaly
- MedGen UID: 52469
- Concept ID: C0038002
- Finding: Finding
Abnormality of the immune system
- Splenomegaly
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.